Clinical Trials · NCT03659682

GLP1R in Parkinson's Disease

UnknownPhase 2Semaglutide (Unclear)
Phase
Phase 2
Recruitment status
Unknown
Sponsor
Oslo University Hospital
Enrollment
120
Start date
Jan 2019
Locations
See registry
Primary endpoint
Motor Function
View Semaglutide compound reference